In the intricate landscape of pharmaceutical research and development, specific chemical intermediates play pivotal roles in enabling the synthesis of complex and life-saving medications. (R)-BoroLeu-(+)-Pinanediol Trifluoroacetate, bearing the CAS number 179324-87-9, is one such critical compound. Its primary significance lies in its application as a key intermediate in the synthesis of Bortezomib, a highly effective proteasome inhibitor used in the treatment of multiple myeloma and other cancers. Understanding the characteristics and sourcing of this intermediate is crucial for pharmaceutical companies and research institutions globally.

Key Chemical Properties and Specifications

This intermediate is characterized by its specific chemical structure, which includes a boronic acid ester linkage protected by a (+)-pinanediol group and a trifluoroacetate counterion. This structure confers stability and reactivity necessary for its role in complex synthetic pathways. Typically supplied as a white powder, (R)-BoroLeu-(+)-Pinanediol Trifluoroacetate boasts a high purity of at least 99%, a crucial specification for pharmaceutical applications. Its molecular formula is C17H29BF3NO4, with a molecular weight of approximately 379.22 g/mol. As a trusted manufacturer from China, we ensure that our product adheres to these stringent quality standards, providing researchers and manufacturers with a reliable building block.

Application in Anti-Cancer Drug Synthesis

The therapeutic significance of Bortezomib, a targeted cancer therapy, directly highlights the importance of its intermediates. (R)-BoroLeu-(+)-Pinanediol Trifluoroacetate is integral to the multi-step synthesis of Bortezomib, enabling the precise construction of its active pharmaceutical ingredient (API). By providing a high-quality intermediate, manufacturers like us contribute directly to the accessibility and efficacy of cancer treatments. The demand for this compound underscores its essential function in modern medicine, making reliable procurement a priority for drug developers.

The Value of a Direct Manufacturer Partnership

For businesses operating in the pharmaceutical sector, establishing a direct relationship with a chemical manufacturer offers significant advantages. When you choose to purchase (R)-BoroLeu-(+)-Pinanediol Trifluoroacetate from us, you benefit from direct sourcing, which typically ensures more competitive pricing and better control over the supply chain. We provide comprehensive technical documentation, including detailed specifications, batch analysis reports (CoA), and safety data (MSDS), supporting your quality assurance and regulatory needs. Our manufacturing capabilities in China are geared towards meeting both small-scale R&D requirements and larger industrial demands, ensuring a consistent and dependable supply.

Procurement and Technical Support

We are committed to supporting scientific innovation by making essential pharmaceutical intermediates readily available. If your research or manufacturing process requires (R)-BoroLeu-(+)-Pinanediol Trifluoroacetate, we encourage you to contact us for a quotation or to discuss your specific needs. Our team is equipped to provide the technical assistance and reliable product supply necessary for the successful development and production of advanced pharmaceutical products.